Industries > Pharma > Precision Medicine Market Report 2020-2030
Precision Medicine Market Report 2020-2030
Forecasts by Therapeutics (Cancer, Cardiovascular, Central Nervous System, Infectious Diseases, Immunology, Others), by Technology (Companion Diagnostics, Biomarkers, Biobanking in Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics), by End Users (Pharma & Biotech, Diagnostic Tool Companies, Healthcare IT/Big Data Companies, Clinical Laboratories), Profiles of Leading Companies and Regional and Leading National Market Analysis
Precision Medicine–our new study reveals trends, R&D progress, and predicted revenues
Where is the Precision Medicine market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 375 pages report provides 271 tables, 267 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Precision Medicine Market. See how to exploit the opportunities.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are following segments, each forecasted at a global and regional level.
Precision Medicine Market by Therapeutics
• Cancer
• Cardiovascular
• Central Nervous System
• Infectious Diseases
• Immunology
• Others
Precision Medicine Market by Technology
• Companion Diagnostics
• Biomarkers
• Biobanking in Targeted Therapeutics
• Pharmacogenomics
• Molecular Diagnostics
Precision Medicine Market by End Users
• Pharma & Biotech
• Diagnostic Tool Companies
• Healthcare IT/Big Data Companies
• Clinical Laboratories
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 22 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Italy
• Spain
• Belgium
• Switzerland
• Rest of Europe
Asia Pacific
• Japan
• China
• India
• Australia
• Singapore
• The Philippines
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
Middle East and Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Precision Medicine market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Precision Medicine Market will surpass $67 billion in 2020, our work calculates. We predict strong revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Precision Medicine Market report helps you
In summary, our 375 pages report provides you with the following knowledge:
• Revenue forecasts to 2030 for 5 regional and 22 key national markets– See forecasts for the Precision Medicine market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Germany, France, UK, Italy, Spain, Belgium, Switzerland, China, India, Japan, Australia, Singapore, The Philippines, South Korea. UAE, Saudi Arabia and South Africa.
• Prospects for established firms and those seeking to enter the market– including company profiles for 14 of the major companies involved in the Precision Medicine market i.e. Abbott, GE Healthcare, Johnson & Johnson Services, Inc., Pfizer Inc., Laboratory Corporation of America Holdings, Danaher, Qiagen N.V., Thermo Fisher Scientific Inc., Illumina, Inc., Novartis AG, GSK, Merck KGaA, F. Hoffmann-La Roche Ltd, and Amgen Inc.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Precision Medicine market and leading companies. You will find data, trends and predictions.
Get our report today Precision Medicine Market Report 2020-2030: Forecasts by Therapeutics (Cancer, Cardiovascular, Central Nervous System, Infectious Diseases, Immunology, Others), by Technology (Companion Diagnostics, Biomarkers, Biobanking in Targeted Therapeutics, Pharmacogenomics, Molecular Diagnostics), by End Users (Pharma & Biotech, Diagnostic Tool Companies, Healthcare IT/Big Data Companies, Clinical Laboratories), Profiles of Leading Companies and Regional and Leading National Market Analysis.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1 Report Overview
1.1 Why You Should Read This Report
1.2 What This Report Delivers
1.3 Key Questions Answered by This Analytical Report Include:
1.4 Who is This Report For?
1.5 Methodology
1.6 Frequently Asked Questions (FAQs)
1.7 Associated Visiongain Reports
1.8 About Visiongain
2 Market Scope: Precision Medicine
2.1 Precision Medicine Market Definition
2.2 Precision Medicine Market: Introduction
2.3 Evolution and Brief History of Precision Medicine
2.4 Key Benefits of Precision Medicine
2.5 Precision Medicine: Key Areas of Application
2.6 Precision Medicine: Key Elements
2.7 Precision Medicine: Different Type of Data Used by Big Data Companies
2.8 Precision Medicine: Area of Interest
3 Global Precision Medicine Market Overview
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Challenges Faced by Precision Medicine Market
3.1.3 Restraints Faced by Precision Medicine Market
3.1.4 Key Opportunities
3.2 SWOT Analysis
3.2.1 Strengths
3.2.2 Weaknesses
3.2.3 Opportunities
3.2.4 Threats
3.3 Industry analysis - Porter’s
3.3.1 Degree of competition
3.3.2 Supplier power
3.3.3 Buyer power
3.3.4 Threat from substitutes
3.3.5 Threat of new entrants
3.4 Industry analysis – PEST
3.4.1 Political
3.4.2 Economical
3.4.3 Social
3.4.4 Technological
3.5 Value Chain Analysis
3.5.1 Device Manufacturer & Drug Producers
3.5.2 Healthcare Providers
3.5.3 Healthcare IT Or Big Data Companies
3.5.4 Regulators
3.5.5 Third Party Payers
3.5.6 Patients
3.6 COVID-19 Impact Analysis
3.6.1 Role of Precision Medicine
3.6.2 Cancer Patients Assessment and Treatment Priority Determination (Top, Intermediate & Low Priority)
3.6.3 Global Precision Medicine Market Forecast by Therapeutics, (Pre-COVID-19)
3.6.4 Global Precision Medicine Market Forecast by Technology, (Pre-COVID-19)
3.6.5 Global Precision Medicine Market Forecast by End-Users, (Pre-COVID-19)
3.6.6 Global Precision Medicine Market Forecast by Region, (Pre-COVID-19)
4 Global Precision Medicine Market Size Forecast 2020-2030 by Therapeutics
4.1 Cancer
4.1.1 Recovery Forecast, 2020-2030 (V, U, W, L)
4.2 Cardiovascular
4.2.1 Recovery Forecast, 2020-2030 (V, U, W, L)
4.3 CNS
4.3.1 Recovery Forecast, 2020-2030 (V, U, W, L)
4.4 Infectious Diseases
4.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
4.5 Immunology
4.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
4.6 Others
4.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
5 Global Precision Medicine Market Size Forecast 2020-2030 by Technology
5.1 Companion Diagnostics
5.1.1 Recovery Forecast, 2020-2030 (V, U, W, L)
5.2 Biomarkers
5.2.1 Recovery Forecast, 2020-2030 (V, U, W, L)
5.3 Biobanking in Targeted Therapeutics
5.3.1 Recovery Forecast, 2020-2030 (V, U, W, L)
5.4 Pharmacogenomics
5.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
5.5 Molecular Diagnostics
5.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
6 Global Precision Medicine Market Size Forecast 2020-2030 by End Users
6.1 Pharma & Biotech
6.1.1 Recovery Forecast, 2020-2030 (V, U, W, L)
6.2 Diagnostic Tool Companies
6.2.1 Recovery Forecast, 2020-2030 (V, U, W, L)
6.3 Healthcare IT/Big Data Companies
6.3.1 Recovery Forecast, 2020-2030 (V, U, W, L)
6.4 Clinical Laboratories
6.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
7 North America Precision Medicine Market
7.1 North America Precision Medicine Market by Country Revenue Forecast, 2020-2030
7.2 North America Precision Medicine Market Forecast by Therapeutics, 2020-2030
7.3 North America Precision Medicine Market Forecast by Technology, 2020-2030
7.4 North America Precision Medicine Market Forecast by End Users, 2020-2030
7.5 U.S.
7.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
7.6 Canada
7.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8 Europe Precision Medicine Market by Country Revenue Forecast, 2020-2030
8.1 Europe Precision Medicine Market Forecast by Therapeutics, 2020-2030
8.2 Europe Precision Medicine Market Forecast by Technology, 2020-2030
8.3 Europe Precision Medicine Market Forecast by End Users, 2020-2030
8.4 Germany
8.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8.5 France
8.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8.6 UK
8.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8.7 Italy
8.7.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8.8 Spain
8.8.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8.9 Belgium
8.9.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8.10 Switzerland
8.10.1 Recovery Forecast, 2020-2030 (V, U, W, L)
8.11 Rest of Europe
8.11.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9 Asia Pacific Precision Medicine Market by Country Revenue Forecast, 2020-2030
9.1 Asia Pacific Precision Medicine Market Forecast by Therapeutics, 2020-2030
9.2 Asia Pacific Precision Medicine Market Forecast by Technology, 2020-2030
9.3 Asia Pacific Precision Medicine Market Forecast by End Users, 2020-2030
9.4 Japan
9.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9.5 China
9.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9.6 India
9.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9.7 Australia
9.7.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9.8 Singapore
9.8.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9.9 The Philippines
9.9.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9.10 South Korea
9.10.1 Recovery Forecast, 2020-2030 (V, U, W, L)
9.11 Rest of Asia Pacific
9.11.1 Recovery Forecast, 2020-2030 (V, U, W, L)
10 Latin America Precision Medicine Market by Country Revenue Forecast, 2020-2030
10.1 Latin America Precision Medicine Market Forecast by Therapeutics, 2020-2030
10.2 Latin America Precision Medicine Market Forecast by Technology, 2020-2030
10.3 Latin America Precision Medicine Market Forecast by End Users, 2020-2030
10.4 Brazil
10.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
10.5 Mexico
10.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
10.6 Argentina
10.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
10.7 Rest of Latin America
10.7.1 Recovery Forecast, 2020-2030 (V, U, W, L)
11 Middle East and Africa Precision Medicine Market by Country Revenue Forecast, 2020-2030
11.1 Middle East and Africa Precision Medicine Market Forecast by Therapeutics, 2020-2030
11.2 Middle East and Africa Precision Medicine Market Forecast by Technology, 2020-2030
11.3 Middle East and Africa Precision Medicine Market Forecast by End Users, 2020-2030
11.4 UAE
11.4.1 Recovery Forecast, 2020-2030 (V, U, W, L)
11.5 Saudi Arabia
11.5.1 Recovery Forecast, 2020-2030 (V, U, W, L)
11.6 South Africa
11.6.1 Recovery Forecast, 2020-2030 (V, U, W, L)
11.7 Rest of Middle East and Africa
11.7.1 Recovery Forecast, 2020-2030 (V, U, W, L)
12 Leading Companies in the Precision Medicine Market
12.1 Abbott
12.1.1 Company Overview
12.1.2 Financials, 2015-2019 (US$ million, AGR %)
12.1.3 Products / Services
12.1.4 Mergers & Acquisitions (M&A) Activity
12.2 GE Healthcare
12.2.1 Company Overview
12.2.2 Financials, 2015-2019 (US$ million, AGR %)
12.2.3 Products / Services
12.2.4 Mergers & Acquisitions (M&A) Activity
12.3 Johnson & Johnson Services, Inc.
12.3.1 Company Overview
12.3.2 Financials, 2015-2019 (US$ million, AGR %)
12.3.3 Products / Services
12.3.4 Mergers & Acquisitions (M&A) Activity
12.4 Pfizer Inc.
12.4.1 Company Overview
12.4.2 Financials, 2015-2019 (US$ million, AGR %)
12.4.3 Products / Services
12.4.4 Mergers & Acquisitions (M&A) Activity
12.5 Laboratory Corporation of America Holdings
12.5.1 Company Overview
12.5.2 Financials, 2015-2019 (US$ million, AGR %)
12.5.3 Products / Services
12.5.4 Mergers & Acquisitions (M&A) Activity
12.6 Danaher
12.6.1 Company Overview
12.6.2 Financials, 2015-2019 (US$ million, AGR %)
12.6.3 Products / Services
12.6.4 Mergers & Acquisitions (M&A) Activity
12.7 Qiagen N.V.
12.7.1 Company Overview
12.7.2 Financials, 2015-2019 (US$ million, AGR %)
12.7.3 Products / Services
12.7.4 Mergers & Acquisitions (M&A) Activity
12.8 Thermo Fisher Scientific Inc.
12.8.1 Company Overview
12.8.2 Financials, 2015-2019 (US$ million, AGR %)
12.8.3 Products / Services
12.8.4 Mergers & Acquisitions (M&A) Activity
12.9 Illumina Inc.
12.9.1 Company Overview
12.9.2 Total Company Sales 2015-2019
12.9.3 Products / Services
12.9.4 Mergers & Acquisitions (M&A) Activity
12.10 Novartis AG
12.10.1 Company Overview
12.10.2 Total Company Sales, 2015-2018
12.10.3 Products / Services
12.10.4 Mergers & Acquisitions (M&A) Activity
12.11 GSK
12.11.1 Company Overview
12.11.2 Financials, 2015-2019 (US$ million, AGR %)
12.11.3 Products / Services
12.11.4 Mergers & Acquisitions (M&A) Activity
12.12 Merck KGaA
12.12.1 Company Overview
12.12.2 Financials, 2015-2019 (US$ million, AGR %)
12.12.3 Products / Services
12.12.4 Mergers & Acquisitions (M&A) Activity
12.13 F. Hoffmann-La Roche Ltd.
12.13.1 Company Overview
12.13.2 Financials, 2015-2019 (US$ million, AGR %)
12.13.3 Precision Medicine Products / Services
12.13.4 Mergers & Acquisitions (M&A) Activity
12.14 Amgen Inc.
12.14.1 Company Overview
12.14.2 Financials, 2015-2019 (US$ million, AGR %)
12.14.3 Products / Services
12.14.4 Mergers & Acquisitions (M&A) Activity
13 Conclusions and Recommendations
Associated Visiongain Reports
Visiongain Report Sales Order Form
Appendix A: About Visiongain
Appendix B: Visiongain report evaluation form
List of Tables
Table 1. Global Precision Medicine Market CAGR Forecast by Region 2020, 2025, 2030 (CAGR %)
Table 2. Key Benefits of Precision Medicine
Table 3. Key Elements of Precision Medicine
Table 4. Global Precision Medicine Market Forecast by Therapeutics (Pre-COVID-19), 2020-2030 (US$ billion, AGR %, CAGR %)
Table 5. Global Precision Medicine Market Forecast by Technology (Pre-COVID-19), 2020-2030 (US$ billion, AGR %, CAGR %)
Table 6. Global Precision Medicine Market Forecast by End Users (Pre-COVID-19), 2020-2030 (US$ billion, AGR %, CAGR %)
Table 7. Global Precision Medicine Market Forecast by Region (Pre-COVID-19), 2020-2030 (US$ billion, AGR %, CAGR %)
Table 8. Global Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 9. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 10. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 11. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 12. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 13. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 14. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 15. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 16. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 17. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 18. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 19. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 20. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 21. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 22. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 23. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 24. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 25. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 26. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 27. Infectious diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 28. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 29. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 30. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 31. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 32. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 33. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 34. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 35. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 36. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 37. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 38. Others Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 39. Global Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 40. Companion Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 41. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 42. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 43. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 44. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 45. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 46. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 47. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 48. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 49. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 50. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 51. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 52. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 53. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 54. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 55. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 56. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 57. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 58. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 59. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 60. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 61. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 62. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 63. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 64. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 65. Global Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 66. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 67. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 68. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 69. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 70. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 71. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 72. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 73. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 74. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 75. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 76. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 77. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 78. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 79. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 80. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 81. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
Table 82. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 83. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 84. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 85. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 86. North America Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 87. North America Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 88. North America Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 89. U.S. Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 90. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 91. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 92. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 93. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 94. Canada Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 95. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 96. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 97. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 98. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 99. Europe Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 100. Europe Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 101. Europe Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 102. Germany Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 103. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 104. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 105. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 106. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 107. France Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 108. France Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 109. France Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 110. France Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 111. France Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 112. UK Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 113. UK Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 114. UK Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 115. UK Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 116. UK Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 117. Italy Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 118. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 119. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 120. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 121. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 122. Spain Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 123. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 124. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 125. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 126. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 127. Belgium Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 128. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 129. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 130. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 131. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 132. Switzerland Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 133. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 134. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 135. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 136. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 137. Rest of Europe Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 138. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 139. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 140. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 141. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 142. Asia Pacific Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 143. Asia Pacific Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 144. Asia Pacific Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 145. Japan Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 146. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 147. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 148. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 149. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 150. China Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 151. China Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 152. China Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 153. China Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 154. China Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 155. India Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 156. India Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 157. India Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 158. India Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 159. India Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 160. Australia Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 161. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 162. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 163. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 164. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 165. Singapore Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 166. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 167. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 168. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 169. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 170. The Philippines Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 171. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 172. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 173. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 174. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 175. South Korea Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 176. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 177. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 178. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 179. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 180. Rest of Asia Pacific Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 181. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 182. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 183. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 184. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 185. Latin America Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 186. Latin America Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 187. Latin America Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 188. Brazil Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 189. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 190. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 191. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 192. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 193. Mexico Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 194. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 195. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 196. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 197. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 198. Argentina Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 199. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 200. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 201. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 202. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 203. Rest of Latin America Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 204. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 205. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 206. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 207. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 208. Middle East and Africa Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 209. Middle East and Africa Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 210. Middle East and Africa Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR %, CAGR %)
Table 211. UAE Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 212. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 213. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 214. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 215. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 216. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 217. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 218. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 219. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 220. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 221. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 222. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 223. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 224. Rest of Middle East and Africa Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
Table 225. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): V Shaped Recovery
Table 226. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): U Shaped Recovery
Table 227. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): W Shaped Recovery
Table 228. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%): L Shaped Recovery
Table 229. Abbott Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 230. Abbott: Financials, 2015-2019 (US$ million, AGR %)
Table 231. Abbott: Recent Developments (Date, Development, Details)
Table 232. GE Healthcare Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 233. GE Healthcare: Financials, 2015-2019 (US$ million, AGR %)
Table 234. GE Healthcare: Recent Developments (Date, Development, Details)
Table 235. Johnson & Johnson Services, Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 236. Johnson & Johnson Services, Inc.: Financials, 2015-2019 (US$ million, AGR %)
Table 237. Johnson & Johnson Services, Inc.: Recent Developments (Date, Development, Details)
Table 238. Pfizer Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 239. Pfizer Inc.: Financials, 2015-2019 (US$ million, AGR %)
Table 240. Pfizer Inc.: Recent Developments (Date, Development, Details)
Table 241. Laboratory Corporation of America Holdings Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 242. Laboratory Corporation of America Holdings: Total Company Sales 2015-2018 (US$ million, AGR %)
Table 243. Laboratory Corporation of America Holdings: Recent Developments (Date, Development, Details)
Table 244. Danaher Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 245. Danaher: Financials, 2015-2019 (US$ million, AGR %)
Table 246. Danaher: Recent Developments (Date, Development, Details)
Table 247. Qiagen N.V. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 248. Qiagen N.V.: Financials, 2015-2019 (US$ million, AGR %)
Table 249. Qiagen N.V.: Recent Developments (Date, Development, Details)
Table 250. Thermo Fisher Scientific Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 251. Thermo Fisher Scientific Inc.: Financials, 2015-2019 (US$ million, AGR %)
Table 252. Thermo Fisher Scientific Inc.: Recent Developments (Date, Development, Details)
Table 253. Illumina Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 254. Illumina Inc.: Financials, 2015-2019 (US$ million, AGR %)
Table 255. Illumina Inc.: Recent Developments (Date, Development, Details)
Table 256. Novartis AG Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 257. Novartis AG: Financials, 2015-2019 (US$ million, AGR %)
Table 258. Novartis AG: Recent Developments (Date, Development, Details)
Table 259. GSK Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 260. GSK: Financials, 2015-2019 (US$ million, AGR %)
Table 261. GSK: Recent Developments (Date, Development, Details)
Table 262. Merck KGaA Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 263. Merck KGaA: Financials, 2015-2019 (US$ million, AGR %)
Table 264. Merck KGaA: Recent Developments (Date, Development, Details)
Table 265. F. Hoffmann-La Roche Ltd. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 266. F. Hoffmann-La Roche Ltd.: Financials, 2015-2019 (US$ million, AGR %)
Table 267. F. Hoffmann-La Roche Ltd.: Recent Developments (Date, Development, Details)
Table 268. Amgen Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 269. Amgen Inc.: Financials, 2015-2019 (US$ million, AGR %)
Table 270. Amgen Inc.: Recent Developments (Date, Development, Details)
Table 271. Global Precision Medicine Market CAGR Forecast by Region 2020, 2025, 2030 (CAGR %)
List of Figures
Figure 1. History of Precision Medicine
Figure 2. Key Areas of Application for Precision Medicine
Figure 3. Key Different Type of Data Used by Big Data Companies in Precision Medicine
Figure 4. Key Areas of Interest for Precision Medicine
Figure 5. Market Dynamics
Figure 6. SWOT Analysis
Figure 7. Porter’s Analysis
Figure 8. PEST Analysis
Figure 9. Precision Medicine Market Value Chain
Figure 10. Global Precision Medicine Market Forecast by Therapeutics (Pre COVID-19), 2020-2030 (US$ billion, AGR %)
Figure 11. Global Precision Medicine Market Forecast by Technology (Pre COVID-19), 2020-2030 (US$ billion, AGR %)
Figure 12. Global Precision Medicine Market Forecast by End Users (Pre COVID-19), 2020-2030 (US$ billion, AGR %)
Figure 13. Global Precision Medicine Market Forecast by Region (Pre COVID-19), 2020-2030 (US$ billion, AGR %)
Figure 14. Global Precision Medicine Market by Therapeutics
Figure 15. Global Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR %)
Figure 16. Global Precision Medicine Market Share Forecast by Therapeutics, 2020, 2025, 2030 (%)
Figure 17. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 18. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 19. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 20. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 21. Cancer Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 22. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 23. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 24. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 25. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 26. Cardiovascular Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 27. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 28. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 29. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 30. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 31. CNS Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 32. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 33. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 34. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 35. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 36. Infectious Diseases Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 37. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 38. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 39. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 40. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 41. Immunology Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 42. Others Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 43. Others Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 44. Others Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 45. Others Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 46. Others Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 47. Global Precision Medicine Market by Technology
Figure 48. Global Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR %)
Figure 49. Global Precision Medicine Market Share Forecast by Technology, 2020, 2025, 2030 (%)
Figure 50. Companion Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 51. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 52. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 53. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 54. Companion diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 55. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 56. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 57. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 58. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 59. Biomarkers Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 60. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 61. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 62. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 63. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 64. Biobanking in Targeted Therapeutics Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 65. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 66. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 67. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 68. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 69. Pharmacogenomics Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 70. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 71. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 72. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 73. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 74. Molecular Diagnostics Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 75. Global Precision Medicine Market by End Users
Figure 76. Global Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR %)
Figure 77. Global Precision Medicine Market Share Forecast by End Users, 2020, 2025, 2030 (%)
Figure 78. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 79. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 80. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 81. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 82. Pharma & Biotech Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 83. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 84. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 85. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 86. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 87. Diagnostic Tool Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 88. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 89. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 90. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 91. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 92. Healthcare IT/Big Data Companies Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 93. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%)
Figure 94. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 95. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 96. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 97. Clinical Laboratories Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 98. North America Precision Medicine Market Forecast by Country 2020-2030 (US$ billion, AGR %)
Figure 99. North America Precision Medicine Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 100. North America Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR%)
Figure 101. North America Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR%)
Figure 102. North America Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR%)
Figure 103. U.S. Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 104. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 105. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 106. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 107. U.S. Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 108. Canada Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 109. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 110. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 111. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 112. Canada Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 113. Europe Precision Medicine Market Forecast by Country 2020-2030 (US$ billion, AGR %)
Figure 114. Europe Precision Medicine Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 115. Europe Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR%)
Figure 116. Europe Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR%)
Figure 117. Europe Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR%)
Figure 118. Germany Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR%)
Figure 119. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 120. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 121. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 122. Germany Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 123. France Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 124. France Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 125. France Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 126. France Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 127. France Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 128. UK Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 129. UK Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 130. UK Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 131. UK Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 132. UK Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 133. Italy Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 134. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 135. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 136. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 137. Italy Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 138. Spain Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 139. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 140. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 141. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 142. Spain Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 143. Belgium Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 144. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 145. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 146. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 147. Belgium Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 148. Switzerland Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 149. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 150. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 151. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 152. Switzerland Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 153. Rest of Europe Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 154. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 155. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 156. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 157. Rest of Europe Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 158. Asia Pacific Precision Medicine Market Forecast by Country 2020-2030 (US$ billion, AGR %)
Figure 159. Asia Pacific Precision Medicine Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 160. Asia Pacific Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR%)
Figure 161. Asia Pacific Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR%)
Figure 162. Asia Pacific Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR%)
Figure 163. Japan Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 164. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 165. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 166. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 167. Japan Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 168. China Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 169. China Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 170. China Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 171. China Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 172. China Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 173. India Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 174. India Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 175. India Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 176. India Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 177. India Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 178. Australia Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 179. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 180. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 181. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 182. Australia Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 183. Singapore Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 184. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 185. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 186. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 187. Singapore Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 188. The Philippines Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 189. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 190. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 191. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 192. The Philippines Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 193. South Korea Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 194. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 195. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 196. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 197. South Korea Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 198. Rest of Asia Pacific Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 199. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 200. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 201. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 202. Rest of APAC Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 203. Latin America Precision Medicine Market Forecast by Country 2020-2030 (US$ billion, AGR %)
Figure 204. Latin America Precision Medicine Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 205. Latin America Precision Medicine Market Forecast by Therapeutics, 2020-2030 (US$ billion, AGR%)
Figure 206. Latin America Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR%)
Figure 207. Latin America Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR%)
Figure 208. Brazil Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 209. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 210. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 211. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 212. Brazil Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 213. Mexico Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 214. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 215. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 216. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 217. Mexico Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 218. Argentina Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 219. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 220. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 221. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 222. Argentina Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 223. Rest of Latin America Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 224. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 225. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 226. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 227. Rest of LATAM Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 228. Middle East and Africa Precision Medicine Market Forecast by Country 2020-2030 (US$ billion, AGR %)
Figure 229. Middle East and Africa Precision Medicine Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 230. Middle East & Africa Precision Medicine Market Forecast by Technology, 2020-2030 (US$ billion, AGR%)
Figure 231. Middle East & Africa Precision Medicine Market Forecast by End Users, 2020-2030 (US$ billion, AGR%)
Figure 232. UAE Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 233. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 234. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 235. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 236. UAE Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 237. Saudi Arabia Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 238. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 239. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 240. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 241. Saudi Arabia Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 242. South Africa Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 243. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 244. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 245. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 246. South Africa Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 247. Rest of Middle East and Africa Precision Medicine Market Forecast 2020-2030 (US$ billion, AGR %)
Figure 248. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%): V Shaped Recovery
Figure 249. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%): U Shaped Recovery
Figure 250. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%): W Shaped Recovery
Figure 251. Rest of MEA Revenue Forecast 2020-2030 (US$ billion, AGR%): L Shaped Recovery
Figure 252. Abbott: Financials, 2015-2019 (US$ million, AGR %)
Figure 253. GE Healthcare: Financials, 2015-2019 (US$ million, AGR %)
Figure 254. Johnson & Johnson Services, Inc.: Financials, 2015-2019 (US$ million, AGR %)
Figure 255. Pfizer Inc.: Financials, 2015-2019 (US$ million, AGR %)
Figure 256. Laboratory Corporation of America Holdings Total Company Sales 2015-2018 (US$ million, AGR %)
Figure 257. Danaher: Financials, 2015-2019 (US$ million, AGR %)
Figure 258. Qiagen N.V.: Financials, 2015-2019 (US$ million, AGR %)
Figure 259. Thermo Fisher Scientific Inc. Total Company Sales 2015-2018 (US$ million, AGR %)
Figure 260. Illumina Inc.: Financials, 2015-2019 (US$ million, AGR %)
Figure 261. Novartis AG Total Company Sales 2015-2018 (US$ million, AGR %)
Figure 262. GSK: Financials, 2015-2019 (US$ million, AGR %)
Figure 263. Merck KGaA: Financials, 2015-2019 (US$ million, AGR %)
Figure 264. F. Hoffmann-La Roche Ltd.: Financials, 2015-2019 (US$ million, AGR %)
Figure 265. Amgen Inc.: Financials, 2015-2019 (US$ million, AGR %)
Figure 266. Global Precision Medicine Market Forecast by Region 2020-2030 (US$ billion, AGR %)
Figure 267. Global Precision Medicine Market Share Forecast by Region 2020, 2025, 2030 (%)
Abbott
Amgen Inc.
Danaher
F. Hoffmann-La Roche Ltd
GE Healthcare
GSK
Illumina, Inc.
Johnson & Johnson Services, Inc.
Laboratory Corporation of America Holdings
Merck KGaA
Novartis AG
Pfizer Inc.
Qiagen N.V.
Thermo Fisher Scientific Inc.
Organizations Mentioned:
American Association for Cancer Research (AACR)
American Medical Association
American National Standards Institute (ANSI)
American Telemedicine Association
Association for Molecular Pathology
Beth Israel Deaconess Medical Center (BIDMC)
Biobank Japan-Riken Institute
Biobanque de Picardie
Biological Resources Centres
Canadian Biosample Repository
Canadian Federal Government
Canadian Institutes of Health Research (CIHR)
Cancer Research Network of the FRSQ
Capital Health/Regional Tissue Bank
Careggi University Hospital
Central Biomaterial Bank
Centre for Disease Control and Prevention (CDC)
Charité-Universitätsmedizin Berlin
Confederation of Cancer Biobanks
Danubian Biobank Consortium Tissue Bank
Drug Enforcement Agency (DEA)
European Association for Cancer Research (EACR)
European Diagnostics Manufacturers Association (EDMA)
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Medicines Agency (EMA)
European Society of Human Genetics
Food and Drug Administration (FDA)
Genethon DNA and Cell Bank
German Heart Failure Network
Global Medical Technology Alliance (GMTA)
Health Science Research Resources Bank/Japan Health Science Foundation
Healthcare information and management systems society (HIMSS)
International Human Genome Sequencing Consortium
International Medical Device Regulators Forum (IMDRF)
Japan National Cancer Center Brain Bank for Aging Research
Japanese Collection of Research Bioresources
King’s College Infectious Diseases Biobank
Liverpool Tissue Bank
Manitoba Breast Tumour Bank
National Institutes of Health (NIH)
NHS Cod Blood Bank
Norwegian University of Science and Technology
Office of the national coordinator for health information technology (ONC HIT)
Ohio State University
Ontario Cancer Research Network
Organization of European Cancer Institute (OECI)
Patient DNA collection at Institute of Human Genetics Heidelberg
Patient-Centered Outcomes Research Institute (PCORI)
Pharmaceutical and medical devices agency (PMDA)
PROCURE Quebec Prostate Cancer
Southwest France Tumour Bank
The Brain Tumour Tissue Bank
The Center for Assessment Technology and Continuous Health (CATCH)
The National Center for Toxicological Research (NCTR)
The National Health Services (NHS)
The National Institute for Health Research (NIHR)
Therapeutic Goods Administration (TGA)
Triangle Global Health Consortium
Tumour Bank of Provence
U.K. Biobank Roslin Wellcome Trust Tick Cell Biobank
U.K. DNA Banking Network
U.K. Stem Cell Bank
United Kingdom Clinical Research Network (UKCRN)
University Hospital of Lausanne and University of Lausanne
University of Bristol
University of Massachusetts Medical School
University of Tartu
Wireless-Life Sciences Alliance (WLSA)
World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Precision Medicine Market Report 2020-2030Related reports
Global Biosimilars and Follow-On Biologics Market 2020-2030
The global biosimilars and follow-on biologics market is estimated to have reached $19.87bn in 2019 and expected to grow at...
Full DetailsPublished: 30 April 2020Active Pharmaceutical Ingredient Market Report 2020-2030
Where is the Active Pharmaceutical Ingredient market heading? If you are involved in this sector you must read this newly...
Full DetailsPublished: 01 January 1970Molecular Diagnostics Market Report 2020-2030
Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets...
Full DetailsPublished: 01 January 1970Biopharmaceuticals Contract Manufacturing Market Report 2020-2030
As of 2019, the global biopharmaceuticals market’s size was estimated at ~$232 billion. It is expected to grow at a...
Full DetailsPublished: 04 March 2020Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2020-2030
Overall world revenue for CMO of sterile injectable drugs will surpass US$55.33 billion by 2030, our work calculates. We predict...
Full DetailsPublished: 01 May 2020Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2020-2030
Overall world revenue for Cancer Immunotherapy Drug Discovery Outsourcing will surpass $750 million in 2020, our work calculates. We predict...
Full DetailsPublished: 01 January 1970Anaesthesia & Respiratory Devices Market Report 2020-2030
The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in...Full DetailsPublished: 24 November 2020Oncology Companion Diagnostics Market Forecast 2020-2030
Along with revenue prediction for the overall world market, there are 3 segmentations of the Oncology Companion Diagnostics market, with...
Full DetailsPublished: 01 January 1970Global Biomarkers Market Forecast to 2029
The global biomarkers market is expected to grow at a CAGR of 9.9% in the first half of the forecast...
Full DetailsPublished: 11 February 2019Oncology Information Systems Market Report 2020-2030
Our study lets you assess forecasted sales at overall world market and regional level. See financial performance of companies, trends,...
Full DetailsPublished: 01 January 1970
Download sample pages
Complete the form below to download your free sample pages for Precision Medicine Market Report 2020-2030Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033
The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033
24 May 2023
Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033
23 May 2023
Visiongain Publishes Single-use Bioprocessing Probes & Sensors Market Report 2023-2033
The global Single-Use Bioprocessing Probes & Sensors market was valued US$2,493.8 million in 2022 and is projected to grow at a CAGR of 15.2% during the forecast period 2023-2033.
22 May 2023
Visiongain Publishes Dental Consumables Market Report 2023-2033
The global Dental Consumables market is valued at US$21,759.4 million in 2023 and is expected to register a CAGR of 8% from 2023 to 2033.
22 May 2023
